No Detail Found!

Berberine inhibits the glycolysis and proliferation of hepatocellular carcinoma cells by down-regulating HIF-1α

Author(s)
Lin Chen Department of Pharmacy, the First Affiliated Hospital of Soochow University,Suzhou City, Jiangsu Province,China
Yeqin Mao Department of Pharmacy, the First Affiliated Hospital of Soochow University,Suzhou City, Jiangsu Province,China
Abstract
Berberine (BBR), an isoquinoline alkaloid abundant in Coptis chinensis, exhibits anti-tumor and hypoglycemic properties. The regulation of tumor cell homeostasis and metabolism is greatly influenced by Hypoxiainducible factor-1a (HIF-1a). This research aims to elucidate whether BBR inhibits the progression of hepatocellular carcinoma (HCC) by modulating HIF-1a expression. Simulating the tumor hypoxic microenvironment in vitro by CoCl2 addition to induce the HIF-1a expression. The optimal concentration of BBR and CoCl2 were screened by CCK-8 assay. Clone formation, wound healing, EDU staining, Transwell assay, and flow cytometry evaluated the malignant biological behavior of HepG2 cells. RT-qPCR and Western blot assessed HIF-1a and glycolysis-related protein levels. Finally, the influence of BBR in vivo was investigated by a xenograft tumor model in nude mice. After exposure to 100 µmol/L BBR, the proliferation, migration and invasion of HepG2 cells were reduced, along with apoptosis was increased, while the levels of glycolysis-related proteins were decreased (P<0.05). 100 µmol/L CoCl2 treatment increased the level of HIF-1a, promoted the malignant progression of HCC and attenuated the anti-tumor effect of BBR. Additionally, BBR inhibited tumor growth in nude mice. In conclusion, BBR exerts antitumor effects through upregulating HIF-1a and could be used as a therapeutic agent for HCC.
Publication Details
Page(s) 1351-1363
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 37, Issue: 6, Year: 2024

Request the full text from PASTIC

Keywords
proliferation, Hepatocellular carcinoma, Berberine, HIF-1a, Glycolysis
References
Abbaszadeh Z,Çeşmeli S,Biray Avcı C .2020 .Crucial players in glycolysis: Cancer progress. Gene, 726 : 144158.
Ashrafizadeh M .2024 .Cell death mechanisms in human cancers: Molecular pathways, therapy resistance and therapeutic perspective. J. Can. Biomol. Therap., 1(1) : 17-40.
Cao M,Ren Y,Li Y,Deng J,Su X,Tang Y,Yuan F,Deng H,Yang G,He Z,Liu B,Yao Z,Deng M .2023 .Lnc-ZEB2-19 inhibits the progression and lenvatinib resistance of hepatocellular carcinoma by attenuating the NF-κB signaling pathway through the TRA2A/RSPH14 axis. Int. J. Biol. Sci., 19(12) : 3678-3693.
Chelakkot C,Chelakkot VS,Shin Y,Song K Y .2023 .Modulating glycolysis to improve cancer therapy. Int. J. Mol. Sci, 24(3) : 2606.
Chen K,Li Y,Wang B,Yan X,Tao Y,Song W,Xi Z,He K,Xia Q K .2023 .Patient-derived models facilitate precision medicine in liver cancer by remodeling cellmatrix interaction. Front. Immunol., 14 : 1101324.
Chen Y,Jiang Y,Huang X,Chen L,Yang H,Zhao J,Liang B .2022 .Cordycepin inhibits the growth of hepatocellular carcinoma by regulating the pathway of aerobic glycolysis. Evid. Based Complement. Alternat. Med, 6454482 : .
Chidambaranathan-Reghupaty S,Fisher PB,Sarkar D PB .2021 .Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification. Adv. Cancer Res., 149 : 1-61.
Cogliati B,Yashaswini CN,Wang S,Sia D,Friedman SL .2023 .Friend or foe? The elusive role of hepatic stellate cells in liver cancer. Nat. Rev. Gastroenterol. Hepatol., 20(10) : 647-661.
Dai H,Li M,Yang W,Sun X,Wang P,Wang X,Su J,Wang X,Hu X,Zhao M .2020 .Resveratrol inhibits the malignant progression of hepatocellular carcinoma via MARCH1-induced regulation of PTEN/AKT signaling. Aging, 12(12) : 11717-11731.
Fei M,Li X,Liang S,Zhou S,Wu H,Sun L,Liu Y,Hu Q,Liu L,Wang J .2024 .LncRNA PWRN1 inhibits the progression of hepatocellular carcinoma by activating PKM2 activity. Cancer Lett., 584 : 216620.
Feng J,Li J,Wu L,Yu Q,Ji J,Wu J,Dai W,Guo C .2020 .Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma. J. Exp. Clin. Cancer Res., 39(1) : 126.
Gao X,Liu J,Fan D,Li X,Fang Z,Yan K,Fan Y .2022 .Berberine enhances gemcitabine-induced cytotoxicity in bladder cancer by downregulating Rad51 expression through inactivating the PI3K/Akt pathway. Oncol. Rep, 47(2) : 33.
Habtemariam S .2020 .Berberine pharmacology and the gut micro biota: A hidden therapeutic link. Pharmacol. Res., 155 : 104722.
Hassanipour S,Vali M,Gaffari-Fam S,Nikbakht HA,Abdzadeh E,Joukar F,Pourshams A,Shafaghi A,Malakoutikhah M,Arab-Zozani M,Salehiniya H,Mansour-Ghanaei F .2020 .The survival rate of hepatocellular carcinoma in Asian countries: A systematic review and meta-analysis. EXCLI J, 19 : 108-130.
Hinshaw DC,Shevde LA .2019 .The tumor microenvironment innately modulates cancer progression. Cancer Res., 79(18) : 4557-4566.
Huang R,Zhang L,Jin J,Zhou Y,Zhang H,Lv C,Lu D,Wu Y,Zhang H,Liu S,Chen H,Luan X,Zhang W .2021 .Bruceine D inhibits HIF-1α-mediated glucose metabolism in hepatocellular carcinoma by blocking ICAT/β-catenin interaction. Acta Pharma. Sini. B., 11(11) : 3481-3492.
Jampasri S,Reabroi S,Tungmunnithum D,Parichatikanond W,Pinthong D .2022 .Plumbagin suppresses breast cancer progression by downregulating HIF-1α expression via a PI3K/Akt/mTOR independent pathway under hypoxic condition. , 27(17) : 5716.
Jiang N,Zhao H,Han Y,Li L,Xiong S,Zeng L,Xiao Y,Wei L,Xiong X,Gao P,Yang M,Liu Y,Sun L Y .2020 .HIF-1α ameliorates tubular injury in diabetic nephropathy via HO-1-mediated control of mitochondrial dynamics. Cell Prolif, 53(11) : e12909.
Kheshtchin N and Hadjati J .2022 .Targeting hypoxia and hypoxia-inducible factor-1 in the tumor microenvironment for optimal cancer immunotherapy. J. Cell Physiol, 237(2) : 1285-1298.
Kierans SJ,Taylor CT SJ .2021 .Regulation of glycolysis by the hypoxia-inducible factor (HIF): implications for cellular physiology. J. Physiol, 599(1) : 23-37.
Viatour Kim E,P Kim E .2020 .Hepatocellular carcinoma: old friends and new tricks. Exp. Mol. Med, 52(12) : 1898-1907.
Li J,Dan W,Zhang C,Liu N,Wang Y,Liu J,Zhang S J .2024 .Exploration of berberine against ulcerative colitis via TLR4/NF-κB/HIF-1α pathway by bioinformatics and experimental validation. Drug Des. Devel. Ther., 18 : 2847-2868.
Lin Y,Guo L Y .2022 .GLI1 is involved in HIF-1α- induced migration, invasion, and epithelialmesenchymal transition in glioma cells. Folia Histochem Cytobiol., 60(2) : 156-166.
Liu L,Fan J,Ai G,Liu J,Luo N,Li C .2019 .Berberine in combination with cisplatin induces necroptosis and apoptosis in ovarian cancer cells. Biol. Res., 52(1) : 37.
Liu Z,Liu X,Liang J,Liu Y,Hou X,Zhang M,Li Y,Jiang X Y .2021 .Immunotherapy for hepatocellular carcinoma: Current status and future prospects. Front. Immunol., 12 : 765101.
Och A,Podgórski R,Nowak R .2020 .Biological activity of berberine-A summary update. Toxins, 12(11) : 713.
Paul S,Ghosh S,Kumar S S .2022 .Tumor glycolysis, an essential sweet tooth of tumor cells. Semin. Cancer Biol, 86 : 1216-1230.
Piñero F,Dirchwolf M,Pessoa MG M .2020 .Biomarkers in hepatocellular carcinoma: Diagnosis, prognosis and treatment response assessment. Cells, 9(6) : 1370.
Rashid M,Zadeh LR,Baradaran B,Molavi O,Ghesmati Z,Sabzichi M,Ramezani F M .2021 .Up-down regulation of HIF-1α in cancer progression. Gene, 798 : 145796.
Rauf A,Abu-Izneid T,Khalil AA,Imran M,Shah ZA,Emran TB,Mitra S,Khan Z,Alhumaydhi FA,Aljohani ASM,Khan I,Rahman MM,Jeandet P,Gondal T A .2021 .Berberine as a potential anticancer agent: A comprehensive review. Molecules, 26(23) : 7368.
Rumgay H,Arnold M,Ferlay J,Lesi O,Cabasag CJ,Vignat J,Laversanne M,McGlynn KA,Soerjomataram I .2022 .Global burden of primary liver cancer in 2020 and predictions to 2040. , 77(6) : 1598-1606.
Sarcognato S,Sacchi D,Fassan M,Fabris L,Cadamuro M,Zanus G,Cataldo I,Capelli P,Baciorri F,Cacciatore M,Guido M M .2021 .. Cholangiocarcinoma. Pathologica, 113(3) : 158-169.
Song D,Hao J,Fan D J .2020 .Biological properties and clinical applications of berberine. Front. Med, 14(5) : 564-582.
Sun K,Wu L,Wang S,Deng W .2022 .Antitumor effects of Chinese herbal medicine compounds and their nano-formulations on regulating the immune system microenvironment. Front. Oncol., 12 : 949332.
Sun Y,Zhou Q,Chen F,Gao X,Yang L,Jin X,Wink M,Sharopov FS,Sethi G .2023 .Berberine inhibits breast carcinoma proliferation and metastasis under hypoxic microenvironment involving gut microbiota and endogenous metabolites. Pharmacol. Res., 193 : 106817.
Sung H,Ferlay J,Siegel RL,Laversanne M,Soerjomataram I,Jemal A,Bray F A,Clin A .2020 .GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Global cancer statistics, 71(3) : 209-249.
Vaupel P and Multhoff G .2021 .Revisiting the Warburg effect: Historical dogma versus current understanding. J. Physiol., 599(6) : 1745-1757.
Vishnoi K,Ke R,Saini KS,Viswakarma N,Nair RS,Das S,Chen Z,Rana A,Rana B .2021 .Berberine represses β-Catenin translation involving 4E-BPs in hepatocellular carcinoma cells. Mol. Pharmacol, 99(1) : 1-16.
Wada H,Nagano H,Yamamoto H,Yang Y,Kondo M,Ota H,Nakamura M,Yoshioka S,Kato H,Damdinsuren B,Tang D,Marubashi S,Miyamoto A,Takeda Y,Umeshita K,Nakamori S,Sakon M,Dono K,Wakasa K,Monden M K .2006 .Expression pattern of angiogenic factors and prognosis after hepatic resection in hepatocellular carcinoma: Importance of angiopoietin-2 and hypoxia-induced factor-1 alpha. , 26(4) : 414-423.
Wang K,Chen Q,Shao Y,Yin S,Liu C,Liu Y,Wang R,Wang T,Qiu Y,Yu H Y .2021 .Anticancer activities of TCM and their active components against tumor metastasis. Biomed, 133 : 111044.
Wang Y,Yang Y,Yang Y,Dang Y,Guo Z,Zhuang Q,Zheng X,Wang F,Cheng N,Liu X,Guo W,Zhao B .2023 .Hypoxia induces hepatocellular carcinoma metastasis via the HIF-1α/METTL16/lnc-CSMD1- 7/RBFOX2 axis. , 26(12) : 108495.
Xiao H,Tong R,Cheng S,Lv Z,Ding C,Du C,Xie H,Zhou L,Wu J,Zheng S J .2014 .BAG3 and HIF-1 α coexpression detected by immunohistochemistry correlated with prognosis in hepatocellular carcinoma after liver transplantation. BioMed. Res. Int., 516518 : .
Xiao Y,Yu D Y .2021 .Tumor microenvironment as a therapeutic target in cancer. Pharmacol, 221 : 107753.
Xie L,Dai H,Li M,Yang W,Yu G,Wang X,Wang P,Liu W,Hu X,Zhao M .2019 .MARCH1 encourages tumour progression of hepatocellular carcinoma via regulation of PI3K-AKT-β-catenin pathways. J. Cell. Mol. Med, 23(5) : 3386-3401.
Xiong RG,Huang SY,Wu SX,Zhou DD,Yang ZJ,Saimaiti A,Zhao CN,Shang A,Zhang YJ,Gan RY,Li HB .2022 .Anticancer effects and mechanisms of berberine from medicinal herbs: An update review. Molecules, 27(14) : 4523.
Xu M,Ren L,Fan J,Huang L,Zhou L,Li X,Ye X .2022 .Berberine inhibits gastric cancer development and progression by regulating the JAK2/STAT3 pathway and downregulating IL-6. , 290 : 120266.
Yu Q,Dai W,Ji J,Wu L,Feng J,Li J,Zheng Y,Li Y,Zhang Z,Wu J,Xu J,Guo X,C X,Cell X .2022 .Sodium butyrate inhibits aerobic glycolysis of hepatocellular carcinoma cells via the cmyc/hexokinase 2 pathway. Mol. Med, 26(10) : 3031-3045.
Zeng X,Wan L,Wang Y,Xue J,Yang H,Zhu Y H .2020 .Effect of low dose of berberine on the radioresistance of cervical cancer cells via a PI3K/HIF1 pathway under nutrient-deprived conditions. Int. J. Radiat. Biol, 96(8) : 1060-1067.
Zhao Y,Xing C,Deng Y,Ye C,Peng H C .2024 .HIF1α signaling: Essential roles in tumorigenesis and implications in targeted therapies. Genes Dis., 11(1) : 234-251.
Zheng F,Li J,Ma C,Tang X,Tang Q,Wu J,Chai X,Xie J,Yang XB,Hann SS .2020 .Novel regulation of. , : .
0

Citations

0

Downloads

96

Views